Thomas, Q.D.; Firmin, N.; Mbatchi, L.; Evrard, A.; Quantin, X.; Leenhardt, F.
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key. Int. J. Mol. Sci. 2023, 24, 5518.
https://doi.org/10.3390/ijms24065518
AMA Style
Thomas QD, Firmin N, Mbatchi L, Evrard A, Quantin X, Leenhardt F.
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key. International Journal of Molecular Sciences. 2023; 24(6):5518.
https://doi.org/10.3390/ijms24065518
Chicago/Turabian Style
Thomas, Quentin Dominique, Nelly Firmin, Litaty Mbatchi, Alexandre Evrard, Xavier Quantin, and Fanny Leenhardt.
2023. "Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key" International Journal of Molecular Sciences 24, no. 6: 5518.
https://doi.org/10.3390/ijms24065518
APA Style
Thomas, Q. D., Firmin, N., Mbatchi, L., Evrard, A., Quantin, X., & Leenhardt, F.
(2023). Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key. International Journal of Molecular Sciences, 24(6), 5518.
https://doi.org/10.3390/ijms24065518